language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
ECLECL

$261.06

-0.99
arrow_drop_down0.38%
Current Market·update12 Nov 2025 21:00

$260.06

-1.00
arrow_drop_down0.38%
Pre-market·update13 Nov 2025 11:58
Day's Range
260.19-263.86
52-week Range
221.62-286.04

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-10-28
Next Earnings TimeBefore Market Open
Volume742.88K
Average Volume 30d1.39M

AI ECL Summary

Powered by LiveAI
💰
36.66
Valuation (P/E Ratio)
Higher than industry average, reflecting growth expectations.
📈
0.152
EPS Growth (YoY)
Represents growth from Q2 2024 estimate to Q2 2025 estimate (based on available data, approximation used).
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
79

Ecolab Inc. presents a strong fundamental profile driven by its essential services in water, hygiene, and infection prevention, supported by consistent profitability and a stable business model. Thematic tailwinds related to global health and sustainability are positive. Technical indicators are mixed, suggesting some short-term caution but an overall positive long-term trend.

Very Strong

Thematic

80

Ecolab is well-positioned to benefit from global trends in water scarcity, hygiene awareness, and infection control, which are secular growth drivers for its business. Increasing focus on ESG also aligns with its core offerings.

Strong

Fundamental

81

Ecolab demonstrates strong financial health with consistent revenue growth, robust profitability, and a healthy balance sheet. Its ability to generate significant free cash flow supports its operations and shareholder returns.

Bullish

Technical

73

Ecolab's stock is trading above key moving averages, indicating a generally positive trend. However, some short-term indicators suggest potential for consolidation or minor pullbacks.

FactorScore
Water Scarcity & Management90
Hygiene & Infection Prevention88
ESG & Sustainability Focus85
Industrial Sector Growth70
Regulatory Environment80
FactorScore
Valuation60
Profitability85
Growth70
Balance Sheet Health75
Cash Flow88
FactorScore
Trend Analysis80
Momentum70
Support & Resistance75
Volume70

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Earnings Performance chevron_right

Consistent EPS Growth

The company has consistently beaten earnings estimates for the past five quarters, with an average surprise of 1.38%. Recent EPS for 2024Q1 was $1.55 against an estimate of $1.54.

Financial Health & Liquidity chevron_right

Strong Current Ratio

The current ratio of 1.25 (Current Assets $22.37B / Current Liabilities $17.91B based on Q4 2024 data) indicates a healthy ability to meet short-term obligations.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation chevron_right

High Price-to-Sales Ratio

The Price/Sales (P/S) ratio of 6.5 (TTM) is relatively high, suggesting that the market may be placing a premium on the company's revenue, which could lead to a valuation correction if growth falters.

Profitability & Margins chevron_right

Recent Margin Compression

Net margin for 2024Q4 was 11.8%, a slight decrease from 13.4% in 2024Q4 (though there was an improvement from 9.0% in 2023Q4). Continued margin pressure could impact profitability.

Show More 🔒

Calendar

June 2025

17

Ex-Dividend Date

July 2025

15

Next Dividend Date

July 2025

29

Next Earnings Date

EPS Est.
Revenue Est.

H: $1.94

A: $1.90

L: $1.86

H: 4.08B

A: 4.03B

L: 3.97B

Profile

Websiteecolab.com
Employees (FY)48K
ISINUS2788651006
FIGI-

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four reportable segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, refining, pulp and paper, and petrochemical industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers cleaning and sanitizing products, such as infection prevention, and end-to-end cleaning and contamination control solutions to the healthcare, personal care, and pharmaceutical industries under the Ecolab, Bioquell, Purolite, and Anios brand names. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Seasonals

2025
2024
2023
2022
2021

Price Target

276.21 USD

The 39 analysts offering 1 year price forecasts for ECL have a max estimate of 320.00 and a min estimate of 230.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
285M (100.67%)
Closely held shares
-1.91M (-0.67%)
284M
Free Float shares
285M (100.67%)
Closely held shares
-1.91M (-0.67%)

Capital Structure

Market cap
76.5B
Debt
8.28B
Minority interest
0.00
Cash & equivalents
1.26B
Enterprise value
83.53B

Valuation - Summary

Market Cap
76.5B
Net income
1.61B(2.11%)
Revenue
11.7B(15.29%)
76.5B
Market Cap
76.5B
Net income
1.61B(2.11%)
Revenue
11.7B(15.29%)
Price to earning ratio (P/E)47.50x
Price to sales ratio (P/S)6.50x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
15.74B
COGS
8.9B
Gross Profit
6.84B
OpEx
4.23B
Operating Income
2.61B
Other & Taxes
501.1M
Net Income
2.11B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒